Response to second-line chemotherapy in patients with hormone refractory prostate cancer (HRPC) receiving two sequences of mitoxantrone (M) and taxanes (T)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: W. K. Oh, J. Manola, V. Babcic, N. Harnam, P. W. Kantoff
Institution: Dana-Farber Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2242629472